| Ytd | 20.36% | |
| 1y | 139.86% |
| Open | 6.43 | Prev Close | 6.37 | Low | 6.28 | High | 6.70 | Mkt Cap | 2.11B |
| Vol | 1.93M | Avg Vol | 3.05M | EPS | -0.38 | P/E | -17.39 | Forward P/E | -15.08 |
| Beta | 1.22 | Short Ratio | 10.30 | Inst. Own | 88.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 6.04 | 200-d Avg | 5.29 | 1yr Est | 13.25 |
TSHA News
DALLAS, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the
DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the
CAMBRIDGE, Mass. and DALLAS and TAMPA, Fla.
Goldman Sachs analyst Salveen Richter maintains Taysha Gene Therapies (NASDAQ:TSHA) with a Buy an
Taysha Gene Therapies (TSHA) remains a "Buy," driven by strong TSHA-102 data in Rett Syndrome and pi
Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact
U.S. stock futures up, Nasdaq 100 futures gain 2%. H.B. Fuller shares dip 8.3% on earnings release a
Shares of Micron Technology Inc (NASDAQ: MU) surged in pre-market trading after reporting strong Q3
DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the
Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-
DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the
Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-1
DALLAS, June 22, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the
DALLAS, June 05, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the
Taysha Gene Therapies is now a one-drug company, fully reliant on TSHA-102 for Rett syndrome after d
Taysha Gene Therapies, Inc. (TSHA) Q1 2026 Earnings Call Transcript
DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the C
DALLAS, May 01, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the C
DALLAS, April 29, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the
In vitro data demonstrated self-complementary AAV9 (scAAV9) enabled ~30-fold higher MeCP2 protein ex
Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA - Get Free Report) were up 6.9% during mid-day t
Capricorn Fund Managers Ltd purchased a new stake in Taysha Gene Therapies, Inc. (NASDAQ: TSHA) duri
DALLAS, April 03, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the
U.S. stocks were mixed, with the Dow Jones index falling more than 50 points on Thursday.
https://news.bloomberglaw.com/health-law-and-business/fda-names-vinay-prasad-as-new-head-of-vaccines
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after t
Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $
The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares,
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
On Wednesday, 81 companies hit new 52-week lows.
On Friday, 469 companies hit new 52-week lows.
Thursday's session saw 337 companies set new 52-week lows.
On Wednesday, 479 stocks made new 52-week lows.
On Friday, 135 companies reached new 52-week lows.
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings a
The Dow Jones closed lower by more than 500 points on Wednesday. Investors, meanwhile, focused on so
During Wednesday's trading, 517 companies set new 52-week lows.
Monday saw 825 companies set new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.